Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction
Rabea Hinkel, Sándor Bátkai, Andrea Bähr, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 23, pp. 2923-2935
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

MicroRNAs as therapeutic targets in cardiovascular disease
Bernhard Laggerbauer, Stefan Engelhardt
Journal of Clinical Investigation (2022) Vol. 132, Iss. 11
Open Access | Times Cited: 106
Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review
Francesco Nappi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3630-3630
Open Access | Times Cited: 29
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF‐REVERT trial
Johann Bauersachs, Scott D. Solomon, Stefan D. Anker, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 3, pp. 674-682
Open Access | Times Cited: 16
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Arantxa González, Mark Richards, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 927-943
Open Access | Times Cited: 50
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Susana Ravassa, Begoña López, Thomas A. Treibel, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101194-101194
Open Access | Times Cited: 36
Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development
Timothy A. McKinsey, Roger Foo, Chukwuemeka George Anene-Nzelu, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3482-3498
Open Access | Times Cited: 37
Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
Ida G. Lunde, Karoline Bjarnesdatter Rypdal, Sophie Van Linthout, et al.
Matrix Biology (2024) Vol. 134, pp. 1-22
Closed Access | Times Cited: 7
Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging
Ibrahim Alradwan, Nojoud AL Fayez, Mohammad N. Alomary, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1037-1037
Open Access | Times Cited: 6
Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis
Cong Chen, Jie Wang, Shan Zhang, et al.
Redox Biology (2024) Vol. 76, pp. 103321-103321
Open Access | Times Cited: 6
MicroRNAs: diagnostic, prognostic and therapeutic role in heart failure—a review
Paola Gargiulo, Federica Marzano, Marco Salvatore, et al.
ESC Heart Failure (2022) Vol. 10, Iss. 2, pp. 753-761
Open Access | Times Cited: 23
The Roles of microRNAs in the Cardiovascular System
Francesco Nappi, Sanjeet Singh, Vikram Jitendra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14277-14277
Open Access | Times Cited: 14
MicroRNAs and therapeutic potentials in acute and chronic cardiac disease
Rui Song, Li Zhang
Drug Discovery Today (2024), pp. 104179-104179
Open Access | Times Cited: 5
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure
Rachad Ghazal, Min Wang, Duan Liu, et al.
Circulation Research (2025) Vol. 136, Iss. 7, pp. 773-802
Closed Access
MiR-132-3p activation aggravates renal ischemia-reperfusion injury by targeting Sirt1/PGC1alpha axis
Chenglong Li, Shangting Han, Jiefu Zhu, et al.
Cellular Signalling (2023) Vol. 110, pp. 110801-110801
Closed Access | Times Cited: 12
Soft robotic platform for progressive and reversible aortic constriction in a small-animal model
Luca Rosalia, Sophie X. Wang, Çağlar Öztürk, et al.
Science Robotics (2024) Vol. 9, Iss. 91
Closed Access | Times Cited: 4
Targeting miRNA‐1a and miRNA‐15b: A Novel Combinatorial Strategy to Drive Adult Cardiac Regeneration
Ting Yuan, Meiqian Wu, Chaonan Zhu, et al.
Advanced Science (2025)
Open Access
Comprehensive profiling of tsRNAs in acute coronary syndrome: expression patterns, clinical correlations, and functional insights
Yi He, Jing Wang, Chen Chen, et al.
Human Genetics (2025)
Open Access
CREB1 transcription-activated lncRNA PVT1 promotes cardiac fibrosis via miR-145/HCN1 axis
Chengnan Tian, Shuo Hu, Junjian Yu, et al.
International Journal of Cardiology (2022) Vol. 353, pp. 88-95
Closed Access | Times Cited: 16
NSD2 promotes pressure overload-induced cardiac hypertrophy via activating circCmiss1/TfR1/ferroptosis signaling
Qirong Xu, Jinlong Liu, Rongrong Zhu, et al.
Life Sciences (2023) Vol. 328, pp. 121873-121873
Closed Access | Times Cited: 10
Non-coding RNA therapeutics in the treatment of heart failure
Aleksandra Paterek, Marta Załęska‐Kocięcka, Mateusz Surzykiewicz, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 4, pp. 353-360
Closed Access | Times Cited: 3
Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System
Kaizu Xu, Chungui Chen, Ying Wu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Roles of microRNAs in the Cardiovascular System
Francesco Nappi, Sanjeet Singh, Vikram Jitendra, et al.
(2023)
Open Access | Times Cited: 7
MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure
Huatao Zhou, Weijie Tang, Jinfu Yang, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies
Bart De Geest, Mudit Mishra
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1645-1645
Open Access | Times Cited: 16
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers
Fanyan Luo, Wei Liu, Haisong Bu
Heart Failure Reviews (2022) Vol. 27, Iss. 6, pp. 2211-2221
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top